These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27098652)

  • 1. The heparan sulphate deficient Hspg2 exon 3 null mouse displays reduced deposition of TGF-β1 in skin compared to C57BL/6 wild type mice.
    Shu C; Smith SM; Melrose J
    J Mol Histol; 2016 Jun; 47(3):365-74. PubMed ID: 27098652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated hypertrophy, growth plate maturation, glycosaminoglycan deposition, and exostosis formation in the
    Shu CC; Smith SM; Little CB; Melrose J
    Biochem J; 2019 Jan; 476(2):225-243. PubMed ID: 30563944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achilles and tail tendons of perlecan exon 3 null heparan sulphate deficient mice display surprising improvement in tendon tensile properties and altered collagen fibril organisation compared to C57BL/6 wild type mice.
    Shu CC; Smith MM; Appleyard RC; Little CB; Melrose J
    PeerJ; 2018; 6():e5120. PubMed ID: 30042881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
    Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
    Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunolocalisation of fibrillin-1 and perlecan in the human foetal, and HS-deficient hspg2 exon 3 null mutant mouse intervertebral disc.
    Hayes AJ; Smith SM; Melrose J
    Histochem Cell Biol; 2013 Jan; 139(1):1-11. PubMed ID: 23104139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
    Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
    Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.
    Tran-Lundmark K; Tran PK; Paulsson-Berne G; Fridén V; Soininen R; Tryggvason K; Wight TN; Kinsella MG; Borén J; Hedin U
    Circ Res; 2008 Jul; 103(1):43-52. PubMed ID: 18596265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type XI collagen-perlecan-HS interactions stabilise the pericellular matrix of annulus fibrosus cells and chondrocytes providing matrix stabilisation and homeostasis.
    Smith SM; Melrose J
    J Mol Histol; 2019 Jun; 50(3):285-294. PubMed ID: 30993430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
    Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K
    Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confocal microscopy demonstrates association of LTBP-2 in fibrillin-1 microfibrils and colocalisation with perlecan in the disc cell pericellular matrix.
    Hayes AJ; Gibson MA; Shu C; Melrose J
    Tissue Cell; 2014 Jun; 46(3):185-97. PubMed ID: 24867584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney.
    Rossi M; Morita H; Sormunen R; Airenne S; Kreivi M; Wang L; Fukai N; Olsen BR; Tryggvason K; Soininen R
    EMBO J; 2003 Jan; 22(2):236-45. PubMed ID: 12514129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perlecan-deficient mutation impairs corneal epithelial structure.
    Inomata T; Ebihara N; Funaki T; Matsuda A; Watanabe Y; Ning L; Xu Z; Murakami A; Arikawa-Hirasawa E
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1277-84. PubMed ID: 22266517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone.
    Thompson WR; Modla S; Grindel BJ; Czymmek KJ; Kirn-Safran CB; Wang L; Duncan RL; Farach-Carson MC
    J Bone Miner Res; 2011 Mar; 26(3):618-29. PubMed ID: 20814969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
    Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
    Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
    Arikawa-Hirasawa E; Wilcox WR; Le AH; Silverman N; Govindraj P; Hassell JR; Yamada Y
    Nat Genet; 2001 Apr; 27(4):431-4. PubMed ID: 11279527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perlecan is essential for cartilage and cephalic development.
    Arikawa-Hirasawa E; Watanabe H; Takami H; Hassell JR; Yamada Y
    Nat Genet; 1999 Nov; 23(3):354-8. PubMed ID: 10545953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition.
    Xu Z; Ichikawa N; Kosaki K; Yamada Y; Sasaki T; Sakai LY; Kurosawa H; Hattori N; Arikawa-Hirasawa E
    Matrix Biol; 2010 Jul; 29(6):461-70. PubMed ID: 20541011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma.
    Kazanskaya GM; Tsidulko AY; Volkov AM; Kiselev RS; Suhovskih AV; Kobozev VV; Gaytan AS; Aidagulova SV; Krivoshapkin AL; Grigorieva EV
    Histochem Cell Biol; 2018 Mar; 149(3):235-244. PubMed ID: 29322326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
    Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
    Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphogenetic roles of perlecan in the tooth enamel organ: an analysis of overexpression using transgenic mice.
    Ida-Yonemochi H; Satokata I; Ohshima H; Sato T; Yokoyama M; Yamada Y; Saku T
    Matrix Biol; 2011 Sep; 30(7-8):379-88. PubMed ID: 21933708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.